Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extension Guidelines Unveiled For Comments
Author: Xiaoban Xin Published: August 25, 2021 On August 3, 2021, the China National Intellectual Property Administration (CNIPA) released the Draft Revised Patent Examination Guidelines (“Draft Guidelines”) for comments. The revisions in the Draft Guidelines reflect the recently amended Chinese Patent Law that came into effect on June 1, 2021, and the Draft Revised Implementing Regulations (“Draft Regulations”) of the…
Getting Lost in the Thicket: AbbVie Wields Its Expansive Humira® Patent Portfolio Against Alvotech’s Adalimumab Biosimilar
Author: Andrew J. Storaska Published: June 24, 2021 In the most recent of a series of litigations by AbbVie against manufacturers seeking to market biosimilar versions of Humira®, the world’s most profitable drug, AbbVie initiated an action against Alvotech in the district court for the Northern District of Illinois on April 27, 2021, after Alvotech requested…
Federal appeals court to former Cleveland Assistant Safety Director Edward Eckart: stand trial for First Amendment retaliation
Published: September 1, 2021 The Sixth Circuit held that clearly established First Amendment legal principles made it unlawful for Eckart to retaliate against fire-division battalion chief Sean DeCrane. Click here to view the entire article at The Chandra Law Firm LLC.
What Is The Committee On Foreign Investment In The United States (CFIUS)?
Speaker: John Kabealo Webinar Date: September 10th, 2020 @ 11:00 AM EST Recording: Coming Soon! In recent months, the U.S. has threatened to and succeeded in blocking a number of foreign investments in U.S. businesses. The recent cases involving TikTok, Grindr and more highlight the extraordinary authority vested in the President of the United States to regulate…